SK

Shoman Kasbekar

Principal at Foresite Capital

United States

Overview

Work Experience

FC

Foresite Capital

  • Principal

    2022 - Current

    Foresite is a venture capital fund investing in people and discoveries that can transform biotechnology and healthcare. Investing $5-100M checks, $4B AUM.

  • Senior Associate

    2021 - 2022

  • Associate

    2020 - 2021

RG

Rare Genomics Institute

  • Strategic Partnerships

    2018

    Building alliances with life sciences, medical device, and healthcare companies to increase the impact of RGI’s initiatives to help individuals suffering from rare diseases.

SC

Synthego Corporation

  • Senior Manager, Strategy & BD

    2020 - 2020

    Synthego was founded to revolutionize CRISPR genome editing technology, helping to translate genomics into the clinic and make engineered biological therapies accessible to all patients.

  • Manager, Strategy & BD

    2019 - 2020

  • Associate

    2018 - 2019

DI

DaVita Inc.

  • Senior Analyst

    2016 - 2018

    Drove partnerships for DaVita's $5B+ commercial business. Executed special projects across healthcare reform, market entry/expansion, and value-based care. Redwoods Leadership Program.

SI

Sharecare, Inc.

  • Corporate Development Analyst

    2015 - 2015

    M&A diligence, analytics, and commercial strategy in digital health.

VT

Vanderbilt Technology Transfer & Commercialization

  • Technology Commercialization/Transfer Analyst

    2014 - 2015

    Monetization of Vanderbilt intellectual property in medtech/biotech.

Education

Relevant Websites